Shares of Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) rose 0.9% during trading on Friday . The stock traded as high as $48.96 and last traded at $48.96. Approximately 332 shares were traded during mid-day trading, a decline of 82% from the average daily volume of 1,871 shares. The stock had previously closed at $48.50.
Hikma Pharmaceuticals Stock Performance
The stock’s 50-day moving average is $47.36 and its two-hundred day moving average is $51.50.
Hikma Pharmaceuticals Cuts Dividend
The business also recently disclosed a dividend, which was paid on Monday, September 29th. Shareholders of record on Tuesday, August 19th were issued a dividend of $0.70 per share. This represents a dividend yield of 340.0%. The ex-dividend date of this dividend was Monday, August 18th. Hikma Pharmaceuticals’s dividend payout ratio is 10.34%.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- Overbought Stocks Explained: Should You Trade Them?
- Is Beyond Meat a Buy After Meme Stock Surge? Analysts Say No
- Where Do I Find 52-Week Highs and Lows?
- ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
- ESG Stocks, What Investors Should Know
- Super Micro’s Moment of Truth: A Growth Story Under Pressure
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
